Search details
1.
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.
Blood
; 142(13): 1143-1155, 2023 09 28.
Article
in English
| MEDLINE | ID: mdl-37294920
2.
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
Lab Invest
; 102(9): 957-965, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35488033
3.
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors.
Int J Mol Sci
; 23(24)2022 Dec 18.
Article
in English
| MEDLINE | ID: mdl-36555810
4.
Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status.
Blood Adv
; 2024 May 07.
Article
in English
| MEDLINE | ID: mdl-38713893
5.
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.
Exp Hematol Oncol
; 13(1): 34, 2024 Mar 25.
Article
in English
| MEDLINE | ID: mdl-38528594
6.
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping.
J Med Chem
; 66(16): 11133-11157, 2023 08 24.
Article
in English
| MEDLINE | ID: mdl-37535845
7.
MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.
Front Oncol
; 12: 959407, 2022.
Article
in English
| MEDLINE | ID: mdl-36324569
Results
1 -
7
de 7
1
Next >
>>